This image set from an iodine contrast mammography study was acquired under a single breast compression. The lesion pointed to with the straight arrow can be identified with the 2D image (left), although the tomosynthesis slice (center) shows the distortion associated with the lesion more clearly, and there is also iodine contrast uptake in the lesion in the contrast image (right). The lesion pointed to with the curved arrow has strong iodine uptake, but is not easily identified in the dense areas of the non-contrast mammographic image.

Using an iodinated contrast agent, I-View
Read more

Carestream now offers an oncology reading workflow for PET/CT studies that equips clinicians with new native tools for its enterprise image management system that deliver both quantitative and qualitative information to help improve and expedite the reading process. The latest upgrade for the company’s enterprise image management platform incorporates advanced tools to aid in tumour detection and tracking. This can help radiologists deliver more meaningful reports while also enhancing collaboration with clinicians and patients. Traditional oncology features cannot adequately address the increased demand to be expected for long-term monitoring of oncology patients as the world’s population ages.
The new CT Perfusion and Subtraction modules contain interactive tools to ease the process of analysing and comparing three-dimensional (3D), CT perfusion (CTP) and digital subtraction angiography (DSA) images. This equips users to analyse CT brain perfusion scans for tissue perfusion and tissue blood volume, while X-ray angiography (XA) subtraction capabilities provide a DSA workflow for analysis of vessel blockages in areas with bony or dense soft tissue. Carestream also developed PET segmentation that allows users to examine tumour standardized uptake values (SUV) traces on the PET image without the need for a physical trace on a CT exam. This capability can play an important role in detection of early stage cancers. The company’s streamlined oncology reading workflow includes: automatic fusion of PET, SPECT, CT and MR images; automatic registration between volumetric datasets that provide efficient comparison of multiple time points; synchronized manipulations, colour maps, measurement tools and pre-defined layouts that aid in analysis; reproducible 2D and volumetric lesion segmentation and automated comparison to observe progression over time; threshold segmentation, spheroid region of interest (ROI), metabolic tumour volume (MTV) and total lesion glycolysis (TLG); bookmarks to catalogue lesions and speed future access and precise follow-up data for enhanced patient care. An efficient reading workflow is supported by use of Carestream’s native Vue Reporting module that can present interactive hyperlinks to critical images and automatic inclusion of quantitative analysis in the form of easy-to-understand comparison tables and charts, which oncologists and referring physicians prefer. Vue Reporting also offers bookmarks and lesion management reporting in accordance with international standards such as response evaluation criteria in solid tumours (RECIST). Reports and images can be shared using Carestream’s Vue Motion universal viewer that supports viewing on FDA-approved mobile devices.
Read more

TrueFusion, an application on the new Release 5.0 of the ACUSON SC2000 cardiovascular ultrasound system, integrates ultrasound and angiography images. These integrated images can be used to guide cardiac teams when administering treatment for structural heart disease. Treatment options for structural heart disease are evolving rapidly. Increasingly, these minimally invasive procedures involve multimodality imaging and multidisciplinary clinical teams. To reliably diagnose structural heart disease and perform these complex interventions, clinical teams need detailed, real-time imaging information – specifically, real-time soft tissue and blood flow information from echocardiography as well as 2D imaging information from fluoroscopy – to be visible in one view for common orientation.  Addressing the need for fused images, the new TrueFusion application sends anatomical and functional markers as well as valve models from the ACUSON SC2000’s True Volume transesophageal echocardiography (TEE) transducer to an Artis with PURE angiography system, overlaying ultrasound information with live fluoroscopy images to navigate structural heart procedures. By directly and seamlessly integrating co-registration of Artis fluoro and ACUSON SC2000 echo into the workflow via machine learning-based probe detection and automated registration updates, TrueFusion enables clinical teams to identify soft tissue-based structures  that are provided directly from the integrated ultrasound system.  Not only can echocardiographers and interventionists better communicate and achieve more intuitive anatomical orientation during challenging procedures, but clinical teams potentially can reduce contrast usage and procedure time as well as patient and clinician X-ray exposure.  For the high innovation pace of novel procedures and devices in structural heart disease, data and image integration is now available for clinical decision support and real-time therapy guidance.
Read more

The Resona 7 ultrasound system is powered by the innovative ZONE Sonography Technology, which transforms ultrasound metrics from the conventional signal processing technique of beamforming to channel data based processing. The ZST+ platform incorporates multiple imaging advances: Advanced Acoustic Acquisition, Dynamic Pixel Focusing, Sound Speed Compensation, Advanced Image Processing, and Total Recall Imaging. These features help elevate Resona 7
Read more

The new PICO 7Y single use negative pressure wound therapy system (sNPWT) with AIRLOCK technology includes an innovative integrated Y extension enabling the utilization of two dressings concurrently from one pump, in practice allowing for two wounds to be addressed at the same time, thereby potentially reducing cost.
PICO 7Y sNPWT includes extended soft port and multisite dressings, designed to conform to complex anatomies. It is particularly suited for use on multiple wounds, such as breast surgical procedures. PICO 7Y also includes a check dressing indicator, which is intended to reduce unnecessary dressing changes and wastage and is 23% quieter than the first generation PICO, making it less intrusive for patients.
PICO 7Y is the latest addition to the PICO family of sNPWT products, which have transformed the use of negative pressure wound therapy by making it available to a wider range of outpatients in a cost effective, portable solution. PICO has been shown to significantly reduce wound complications following breast reduction surgery compared with standard dressings. In a breast cancer study with patients undergoing therapeutic mammoplasty, PICO reduced the incidence of post-surgical wound dehiscence by 75% compared with standard care, thereby reducing the potential for delay in the commencement of adjuvant therapy.
Read more